5 min. Read

Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.

Issue 350

Welcome back to E&O: a paying subscribers-only weekly newsletter focused on three areas of health tech: FDA-regulated software devices, digital health as an employee benefit, and national virtual clinics.

Exits & Outcomes Newsletter

This week's newsletter focuses on a new Medical (non?)Coverage Policy from Cigna focused on prescription digital therapeutics. But first... a few quick notes:

New York City-based Bevel, which offers an

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

Newsletters

Oura subscription revs, rings sold, hardware margin. New ACCESS Model participants

6.05.26

7 min. Read

Six years of Oura’s financials: Revenue, profits, marketing spend and more

5.22.26

4 min. Read

ACCESS Model’s first dropout? Plus: A few new participants

5.08.26

6 min. Read

Are these Utah’s next four AI experiments? Plus: More on the Utah Pharmacy Board’s questions about Doctronic

4.17.26

9 min. Read

Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board

4.10.26

13 min. Read

Quiet funding rounds. Plus: Digital health-related clinical trial round-ups

3.20.26

5 min. Read

Details: Vida Health’s brief GLP-1 rollout in Mass. Plus: CMS says Freespira not DME

3.13.26

7 min. Read

AI billing codes for 5-min visits? Cityblock $1.5B ARR.

2.27.26

8 min. Read

K Health shuts down DTC clinic. Big employer customer wins, losses

2.20.26

6 min. Read

ACCESS Model’s shockingly low payments. DMHT Rx count.

2.13.26

7 min. Read

Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.

Exits & Outcomes Newsletter

Sign-up for the newsletter for access.

E&O's weekly newsletter.